Literature DB >> 16430725

Radioiodine therapy and age at menopause in patients with thyroid cancer.

Pedro Weslley Souza Rosario, Tales Alvarenga Fagundes, Aranai Villasboas Fagundes, Alvero Luis Barraso, Leonardo Lamego Rezende, Eduardo Lanza Padrao, Valeria C Guimaraes, Saulo Purisch.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16430725     DOI： 10.1111/j.1365-2265.2005.02413.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN： 0300-0664            Impact factor:   3.478


× No keyword cloud information.
  4 in total

1.  Anti-Müllerian hormone in pre-menopausal females after ablative radioiodine treatment for differentiated thyroid cancer.

Authors:  Massimo Giusti; Miranda Mittica; Paola Comite; Claudia Campana; Stefano Gay; Michele Mussap
Journal:  Endocrine       Date:  2018-01-04       Impact factor: 3.633

2.  Reproductive and gynecological complication risks among thyroid cancer survivors.

Authors:  Brenna E Blackburn; Patricia A Ganz; Kerry Rowe; John Snyder; Yuan Wan; Vikrant Deshmukh; Michael Newman; Alison Fraser; Ken Smith; Kimberley Herget; Jaewhan Kim; Anne C Kirchhoff; Christina Porucznik; Heidi Hanson; Dev Abraham; Marcus Monroe; Mia Hashibe
Journal:  J Cancer Surviv       Date:  2018-08-21       Impact factor: 4.442

3.  Cross-sectional and prospective study on anti-Müllerian hormone changes in a cohort of pre-menopausal women with a history of differentiated thyroid cancer.

Authors:  Miranda Mittica; Andrea Dotto; Martina Comina; Marsida Teliti; Eleonora Monti; Massimo Giusti
Journal:  Thyroid Res       Date:  2020-01-10

4.  Pregnancy Outcome After I-131 Therapy for Patients With Thyroid Cancer: A Nationwide Population-Based Cohort Study.

Authors:  Kuan-Yin Ko; Ruoh-Fang Yen; Cheng-Li Lin; Mei-Fang Cheng; Wen-Sheng Huang; Chia-Hung Kao
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.889
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.